Gossamer Bio Inc (NAS:GOSS)
$ 0.6199 -0.0169 (-2.65%) Market Cap: 140.23 Mil Enterprise Value: 104.89 Mil PE Ratio: 0 PB Ratio: 5.25 GF Score: 37/100

Gossamer Bio Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) Transcript

Oct 19, 2021 / 12:00PM GMT
Release Date Price: $13.05 (-3.12%)
Chris Howerton
(Trades, Portfolio) LLC - Analyst

Hi, everybody. Thank you so much for joining us. This is Chris Howerton, part of the Jefferies biotechnology research team. Very pleased to be hosting the Next Generation IBD Summit, and the next company that will do a short presentation -- and hopefully, we have a little time for Q&A after -- is Gossamer Bio.

And to kick things off for us, we have Faheem Hasnain, the Founder and CEO, to kick this off. So please take it away, sir.

Faheem Hasnain
Gossamer Bio, Inc. - Co-Founder, Chairman, & CEO

Chris, thanks a lot. Thanks very much for inviting us to the IBD Summit. Obviously, obligatory forward-looking statements, and please refer to those as always.

So Gossamer has a very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot